Funding Rounds
Laminar Pharma

Laminar Pharma Series A (2020, $1M)

Laminar Pharma

A biopharmaceutical platform focusing on the discovery, design, and clinical development of new MLT-based drugs.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $1.80M

Raised Date: 2020-01-01